compound 15a   Click here for help

GtoPdb Ligand ID: 10557

Compound class: Synthetic organic
Comment: Compound 15a is a small-molecule agonist of the apelin receptor [1]. It exhibits similar in vitro potency to the endogenous agonist apelin-13, and binds to the orthosteric site of the receptor. Compound 15a was designed by Bristol-Myers Squibb Research and Development.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 3
Rotatable bonds 9
Topological polar surface area 95.08
Molecular weight 523.17
XLogP 8.02
No. Lipinski's rules broken 1
Click here for help
Canonical SMILES CCCC(c1ccccc1)NC(=O)c1ccc(c(c1)C(=O)O)c1c(Cl)cccc1c1nc2c([nH]1)cccc2
Isomeric SMILES CCC[C@H](c1ccccc1)NC(=O)c1ccc(c(c1)C(=O)O)c1c(Cl)cccc1c1nc2c([nH]1)cccc2
InChI InChI=1S/C31H26ClN3O3/c1-2-9-25(19-10-4-3-5-11-19)35-30(36)20-16-17-21(23(18-20)31(37)38)28-22(12-8-13-24(28)32)29-33-26-14-6-7-15-27(26)34-29/h3-8,10-18,25H,2,9H2,1H3,(H,33,34)(H,35,36)(H,37,38)/t25-/m1/s1
Bioactivity Comments
Intravenous infusion of compound 15a induced a dose-dependent improvement in cardiac output in an in vivo rat model, which was consistent with the apelin-13 effect [1].
Selectivity at GPCRs
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
apelin receptor Hs Agonist Agonist 10.0 pEC50 - 1
pEC50 10.0 (EC50 9.3x10-11 M) [1]
Description: Determined in an intracellular cAMP accumulation assay (hTR-FRET) using HEK293 cells stably expressing hAPLNR.